We are live on ! Find out more
PC

Polar Capital Portfolio holdings

AUM $13.5B
1-Year Est. Return 55.9%
This Fund
S&P 500
This Quarter Est. Return
+3.49%
1 Year Est. Return
+55.9%
3 Year Est. Return
+127.44%
5 Year Est. Return
+269.08%
10 Year Est. Return
–
AUM
$6.26B
AUM Growth
+$473M
Cap. Flow
+$398M
Cap. Flow %
6.35%
Top 10 Hldgs %
23.68%
Holding
293
New
38
Increased
125
Reduced
71
Closed
38

Top Buys

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$53.8M
2
ELV icon
Elevance Health
ELV
+$34.6M
3
AET
Aetna Inc
AET
+$33.5M
4
WBA
Walgreens Boots Alliance
WBA
+$32.4M
5
AME icon
Ametek
AME
+$29.1M

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$48.5M
2
MRK icon
Merck
MRK
+$37.3M
3
AMGN icon
Amgen
AMGN
+$35M
4
EW icon
Edwards Lifesciences
EW
+$29.3M
5
BAH icon
Booz Allen Hamilton
BAH
+$26.3M

Sector Composition

Rank Sector Weight
1 Financials 23.24%
2 Technology 21.39%
3 Healthcare 21.13%
4 Communication Services 9.82%
5 Industrials 4.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ISRG icon
251
Intuitive Surgical
ISRG
$128B
– –
-288,000
Closed -$23.2M
JAZZ icon
252
Jazz Pharmaceuticals
JAZZ
$16B
– –
-8,500
Closed -$1.03M
NGD
253
DELISTED
New Gold Inc
NGD
– –
-362,611
Closed -$1.6M
OCUL icon
254
Ocular Therapeutix
OCUL
$1.89B
– –
-57,500
Closed -$395K
RCKT icon
255
Rocket Pharmaceuticals
RCKT
$355M
– –
-18,750
Closed -$711K
SPNT icon
256
SiriusPoint
SPNT
$3.01B
– –
-1,000,000
Closed -$12M
TSM icon
257
TSMC
TSM
$2.07T
– –
-6,640
Closed -$203K
WTW icon
258
Willis Towers Watson
WTW
$28.6B
– –
-110,000
Closed -$14.6M
ZBH icon
259
Zimmer Biomet
ZBH
$17.8B
– –
-190,550
Closed -$24.1M
NVRO
260
DELISTED
NEVRO CORP.
NVRO
– –
-164,000
Closed -$17.1M
NVTA
261
DELISTED
Invitae Corporation
NVTA
– –
-47,500
Closed -$416K
ISEE
262
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
– –
-7,250
Closed -$334K
AUY
263
DELISTED
Yamana Gold, Inc.
AUY
– –
-205,575
Closed -$912K
HSTO
264
DELISTED
Histogen Inc. Common Stock
HSTO
– –
-783
Closed -$311K
TRIL
265
DELISTED
Trillium Therapeutics Inc.
TRIL
– –
-33,000
Closed -$488K
OAK
266
DELISTED
OAKTREE CAPITAL GROUP, LLC
OAK
– –
-77,500
Closed -$3.28M
ELGX
267
DELISTED
Endologix Inc
ELGX
– –
-102,900
Closed -$13.2M
MON
268
DELISTED
Monsanto Co
MON
– –
-17,797
Closed -$1.82M
LLTC
269
DELISTED
Linear Technology Corp
LLTC
– –
-92,576
Closed -$5.49M
N
270
DELISTED
Netsuite Inc
N
– –
-32,424
Closed -$3.59M
7 8 9 10
11

Similar funds

ECM
ETrade Capital Management Arlington, Virginia $5.37B AUM 10.84% 1-Year Est. Return
FAAS
First Allied Advisory Services San Diego, California $2.98B AUM 15.89% 1-Year Est. Return
WAM
Wealthspire Advisors (Maryland) Potomac, Maryland $2.84B AUM 10.91% 1-Year Est. Return
FS
Feinberg Stephen $2.61B AUM 15.12% 1-Year Est. Return
NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return
TI
TT International London, United Kingdom $1.94B AUM
VIM
Veritas Investment Management London, United Kingdom $1.65B AUM 25.54% 1-Year Est. Return
PS
Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return

Polar Capital's Q4 2016 Portfolio in Review

As of Q4 2016, Polar Capital held 293 positions worth $6.26B, up 8.2% from $5.79B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Polar Capital deployed $398M of net new capital in Q4 2016, opening 38 new positions and adding to 125 existing holdings. Its largest new stake was Aetna Inc: 279,500 shares worth $34.7M.

By sector, the portfolio is most concentrated in Financials at 23% of assets, up from 20% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Johnson & Johnson, an estimated $48.5M trimmed.

  • Polar Capital's largest Q4 2016 buy was Aetna Inc: 279,500 shares worth $34.7M.
  • Polar Capital added most to Alexion Pharmaceuticals in Q4 2016, an estimated $53.8M increase.
  • Polar Capital's biggest Q4 2016 reduction was Johnson & Johnson, cutting an estimated $48.5M.
  • Polar Capital fully exited Edwards Lifesciences in Q4 2016, selling an estimated $29.3M.
  • Polar Capital's ten largest holdings make up 24% of its $6.26B portfolio in Q4 2016.
  • Polar Capital opened 38 new positions and closed 38 in Q4 2016.
  • Polar Capital's portfolio value rose 8.2% quarter-over-quarter to $6.26B.

Based on Polar Capital's 13F filing for Q4 2016, filed 14 Feb 2017.